Pangea Biomed Launches with World’s Most Advanced Multi-Cancer Response Predictor, Increasing Patient Benefits from Precision Oncology by 5x
Similar Posts
Biofourmis Selected by Vanderbilt University Medical Center for CAR T-Cell Therapy Study Utilizing Tech-Enabled Remote Patient Monitoring
Oncology patients treated with Kite’s YESCARTA® will be monitored remotely to identify signs of potential adverse side effects;…
AccessHope Announces Collaboration with UT Southwestern Medical Center to Expand Cancer Expertise Access in Southern States
● UT Southwestern Harold C. Simmons Comprehensive Cancer Center is the seventh National Cancer Institute-Designated Comprehensive Cancer Center…
SimonMed’s simonONE Leads National Total-Body Screening Market Boom, Doubles Plus Centers
In a move signaling a surge in the total-body screening market, simonONE by SimonMed, a clinical provider of…
Shelly Annette Bond Adds Leadership and Expertise to Ascom as New VP of Canadian Sales
Ascom, a global solutions provider focused on healthcare information communication technology (ICT) and mobile workflows, has hired Shelly Annette…
